NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Plains GP Holdings, L.P. ("Plains GP" or "the Company") (NASDAQ:PAGP). Investors who purchased Plains GP securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/pagp.
The investigation concerns whether Plains GP and certain of its officers and/or directors have violated federal securities laws.
On February 9, 2021, Plains GP issued a press release reporting fourth-quarter and full-year 2020 financial results. Among other results, Plains GP reported fourth-quarter GAAP earnings-per-share of ‑$0.11, missing estimates by $0.33, and fourth-quarter revenues of $5.96 billion, representing a 34.9% year-to-year decline and missing estimates by $260 million. On this news, Plains GP's stock price fell $0.84 per share, or 8.97%, to close at $8.52 per share on February 10, 2021.
If you are aware of any facts relating to this investigation, or purchased Plains GP shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/pagp. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC